Company News

Share this article:

Sanofi-Aventis acquired Laboratorios Kendrick, a Mexican generic manufacturer. Sanofi hopes the purchase will extend its pharmaceutical portfolio in emerging markets. Laboratorios Kendric recorded sales of approximately $35 million in 2008.

 

Genzyme struck a deal with Bayer HealthCare to assume “primary responsibility” for the worldwide commercialization of Campath, a multiple sclerosis treatment. Genzyme also picked up Bayer's cancer drugs Fludara and Leukine, and will buy Bayer's Leukine manufacturing plant, near Seattle, for $75 - $100 million.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.